UB Paderborn / Katalog / Suche / in CDI

Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice

Alimentary pharmacology & therapeutics, 2024-06, Vol.59 (12), p.1604-1615

2024

Volltextzugriff (PDF)

Ocular biometry in the adult anesthetized ferret (Mustela putorius furo)

Veterinary ophthalmology, 2007-01, Vol.10 (1), p.50-52

2007

Volltextzugriff (PDF)

Determination of cutoff values on computed tomography and magnetic resonance images for the diagnosis of atlantoaxial instability in small‐breed dogs

Veterinary surgery, 2022-05, Vol.51 (4), p.620-630

2022

Volltextzugriff (PDF)

Idiosyncratic Drug-Induced Liver Injury: A 20-Year Update of the Cases Enrolled By the Spanish Dili Registry

Clinical therapeutics, 2017-08, Vol.39 (8), p.e57-e57

2017

Volltextzugriff (PDF)

Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

Journal of hepatology, 2016, Vol.64 (2), p.S319-S319

2016

Volltextzugriff (PDF)

Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients

Hepatology (Baltimore, Md.), 2001-12, Vol.34 (6), p.1158-1163

2001

Volltextzugriff (PDF)

P1178 TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICE

Journal of hepatology, 2014-04, Vol.60 (1), p.S478-S478

2014

Volltextzugriff (PDF)

Discoursive analysis and pragmatic metadiscourse in four sub-areas of Economics research articles

Ibérica (Castellón de la Plana, Spain), 2008 (16), p.81-108

2008

Volltextzugriff (PDF)

174 VON WILLEBRAND FACTOR LEVELS CORRELATE WITH THE SEVERITY OF PORTAL HYPERTENSION AND INDEPENDENTLY PREDICT THE CLINICAL OUTCOME OF CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION

Journal of hepatology, 2010, Vol.52, p.S75-S76

2010

Volltextzugriff (PDF)

Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?

Obesity surgery, 2001-06, Vol.11 (3), p.254-257

2001

Volltextzugriff (PDF)

The role of the actors in the trade network structure of fishing products: The case of the shark market

Ocean & coastal management, 2023-08, Vol.242, p.106680, Article 106680

2023

Volltextzugriff (PDF)

The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity

Liver international, 2015-11, Vol.35 (11), p.2474-2482

2015

Volltextzugriff (PDF)

Discoursive Analysis and Pragmatic Metadiscourse in Four Sub-Areas of Economics Research Articles

Ibérica (Castellón de la Plana, Spain), 2008-10, Vol.16 (fall), p.81-108

2008

Volltextzugriff (PDF)

Diplostomum compactum metacercariae in the eyes of Caquetaia kraussii from Totumo Marsh, north of Colombia

Bulletin of the European Association of Fish Pathologists, 2012-01, Vol.32 (6), p.203-211

2012

Volltextzugriff (PDF)

P0762 : Non-RNA testing among hepatitis C virus antibody-positive patients in a national public health insurance care system: Prevalence, characteristics and predictive factors

Journal of hepatology, 2015-04, Vol.62, p.S615-S615

2015

Volltextzugriff (PDF)

Gap Junction Opener Improves Endothelial Dysfunction and Decreases Hepatic Vascular Resistance in Cirrhotic Rats

Journal of hepatology, 2016, Vol.64 (2), p.S448-S449

2016

Volltextzugriff (PDF)

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

Gastroenterología y hepatología, 2018-08, Vol.41 (7), p.475-476

2018

Volltextzugriff (PDF)

P251 Proactive Therapeutic drug monitoring of Infliximab, but not HLA-DQA105, predicts clinical outcome in inflammatory bowel disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i604-i604

2024

Volltextzugriff (PDF)

P337 Proactive therapeutic drug monitoring of Adalimumab, but not HLADQA1 determination, predicts inflammatory bowel disease outcome and persistence of treatment

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i730-i730

2024

Volltextzugriff (PDF)

P426 Hematological Composite Scores in Patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i878-i878

2024

Volltextzugriff (PDF)

P863 Prospective outcome following ustekinumab treatment in a real-world cohort of inflammatory bowel disease patients

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1598-i1599

2024

Volltextzugriff (PDF)

P268 CHRONIC INTERMITTENT HYPOXIA EXACERBATES ENDOTHELIAL DYSFUNCTION IN NON-ALCOHOLIC FATTY LIVER DISEASE

Journal of hepatology, 2014-04, Vol.60 (1), p.S154-S154

2014

Volltextzugriff (PDF)

O167 ADDITION OF SIMVASTATIN TO STANDARD TREATMENT IMPROVES SURVIVAL AFTER VARICEAL BLEEDING IN PATIENTS WITH CIRRHOSIS. A DOUBLE-BLIND RANDOMIZED TRIAL (NCT01095185)

Journal of hepatology, 2014-04, Vol.60 (1), p.S525-S525

2014

Volltextzugriff (PDF)

P485 Apolipoprotein C3 is Downregulated in Patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i451-i452

2022

Volltextzugriff (PDF)

P437 Early therapeutic drug monitoring of Adalimumab, but not HLADQA1 determination, predicts inflammatory bowel disease outcome

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i566-i566

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice

Ocular biometry in the adult anesthetized ferret (Mustela putorius furo)

Determination of cutoff values on computed tomography and magnetic resonance images for the diagnosis of atlantoaxial instability in small‐breed dogs

Idiosyncratic Drug-Induced Liver Injury: A 20-Year Update of the Cases Enrolled By the Spanish Dili Registry

Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients

P1178 TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICE

Discoursive analysis and pragmatic metadiscourse in four sub-areas of Economics research articles

174 VON WILLEBRAND FACTOR LEVELS CORRELATE WITH THE SEVERITY OF PORTAL HYPERTENSION AND INDEPENDENTLY PREDICT THE CLINICAL OUTCOME OF CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION

Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?

The role of the actors in the trade network structure of fishing products: The case of the shark market

The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity

Discoursive Analysis and Pragmatic Metadiscourse in Four Sub-Areas of Economics Research Articles

Diplostomum compactum metacercariae in the eyes of Caquetaia kraussii from Totumo Marsh, north of Colombia

P0762 : Non-RNA testing among hepatitis C virus antibody-positive patients in a national public health insurance care system: Prevalence, characteristics and predictive factors

Gap Junction Opener Improves Endothelial Dysfunction and Decreases Hepatic Vascular Resistance in Cirrhotic Rats

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

P251 Proactive Therapeutic drug monitoring of Infliximab, but not HLA-DQA105, predicts clinical outcome in inflammatory bowel disease

P337 Proactive therapeutic drug monitoring of Adalimumab, but not HLADQA1 determination, predicts inflammatory bowel disease outcome and persistence of treatment

P426 Hematological Composite Scores in Patients with Inflammatory Bowel Disease

P863 Prospective outcome following ustekinumab treatment in a real-world cohort of inflammatory bowel disease patients

P268 CHRONIC INTERMITTENT HYPOXIA EXACERBATES ENDOTHELIAL DYSFUNCTION IN NON-ALCOHOLIC FATTY LIVER DISEASE

O167 ADDITION OF SIMVASTATIN TO STANDARD TREATMENT IMPROVES SURVIVAL AFTER VARICEAL BLEEDING IN PATIENTS WITH CIRRHOSIS. A DOUBLE-BLIND RANDOMIZED TRIAL (NCT01095185)

P485 Apolipoprotein C3 is Downregulated in Patients with Inflammatory Bowel Disease

P437 Early therapeutic drug monitoring of Adalimumab, but not HLADQA1 determination, predicts inflammatory bowel disease outcome

Suchergebnisse filtern